A detailed history of Chicago Capital, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Chicago Capital, LLC holds 379,582 shares of PRCT stock, worth $23.6 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
379,582
Previous 262,651 44.52%
Holding current value
$23.6 Million
Previous $21 Million 45.26%
% of portfolio
0.82%
Previous 0.59%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

BUY
$67.27 - $99.45 $7.87 Million - $11.6 Million
116,931 Added 44.52%
379,582 $30.6 Million
Q3 2024

Oct 18, 2024

BUY
$56.31 - $84.99 $1.67 Million - $2.52 Million
29,668 Added 12.73%
262,651 $21 Million
Q2 2024

Aug 06, 2024

BUY
$45.73 - $69.19 $10.7 Million - $16.1 Million
232,983 New
232,983 $14.2 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $2.78B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Chicago Capital, LLC Portfolio

Follow Chicago Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital, LLC with notifications on news.